Chitosan Nanoparticles as Oral Drug Carriers. 2023

Omar Rodrigo Guadarrama-Escobar, and Pablo Serrano-Castañeda, and Ericka Anguiano-Almazán, and Alma Vázquez-Durán, and Ma Concepción Peña-Juárez, and Ricardo Vera-Graziano, and Miriam Isabel Morales-Florido, and Betsabe Rodriguez-Perez, and Isabel Marlen Rodriguez-Cruz, and Jorge Esteban Miranda-Calderón, and José Juan Escobar-Chávez
Unidad de Investigación Multidisciplinaria-Lab 12, Facultad de Estudios Superiores Cuautitlán-Universidad Nacional Autónoma de México, Carretera Cuautitlán-Teoloyucan, km 2.5 San Sebastián Xhala, Cuautitlán Izcalli 54714, Mexico.

The use of nanoparticles as drug delivery systems has increased in importance in the last decades. Despite the disadvantages of difficulty swallowing, gastric irritation, low solubility, and poor bioavailability, oral administration stands out as the most widely used route for therapeutic treatments, though it may not always be the most effective route. The effect of the first hepatic pass is one of the primary challenges that drugs must overcome to carry out their therapeutic effect. For these reasons, controlled-release systems based on nanoparticles synthesized from biodegradable natural polymers have been reported to be very efficient in enhancing oral delivery in multiple studies. Chitosan has been shown to have an extensive variability of properties and roles in the pharmaceutical and health fields; of its most important properties are the ability to encapsulate and transport drugs within the body and enhance the drug interaction with the target cells, which improves the efficacy of the encapsulated drugs. The physicochemical properties of chitosan give it the ability to form nanoparticles through multiple mechanisms, which will be addressed in this article. The present review article focuses on highlighting the applications of chitosan nanoparticles for oral drug delivery.

UI MeSH Term Description Entries
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D048271 Chitosan Deacetylated CHITIN, a linear polysaccharide of deacetylated beta-1,4-D-glucosamine. It is used in HYDROGEL and to treat WOUNDS. Poliglusam
D053758 Nanoparticles Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging. Nanocrystalline Materials,Nanocrystals,Material, Nanocrystalline,Materials, Nanocrystalline,Nanocrystal,Nanocrystalline Material,Nanoparticle

Related Publications

Omar Rodrigo Guadarrama-Escobar, and Pablo Serrano-Castañeda, and Ericka Anguiano-Almazán, and Alma Vázquez-Durán, and Ma Concepción Peña-Juárez, and Ricardo Vera-Graziano, and Miriam Isabel Morales-Florido, and Betsabe Rodriguez-Perez, and Isabel Marlen Rodriguez-Cruz, and Jorge Esteban Miranda-Calderón, and José Juan Escobar-Chávez
January 2011, International journal of nanomedicine,
Omar Rodrigo Guadarrama-Escobar, and Pablo Serrano-Castañeda, and Ericka Anguiano-Almazán, and Alma Vázquez-Durán, and Ma Concepción Peña-Juárez, and Ricardo Vera-Graziano, and Miriam Isabel Morales-Florido, and Betsabe Rodriguez-Perez, and Isabel Marlen Rodriguez-Cruz, and Jorge Esteban Miranda-Calderón, and José Juan Escobar-Chávez
January 2015, Journal of microencapsulation,
Omar Rodrigo Guadarrama-Escobar, and Pablo Serrano-Castañeda, and Ericka Anguiano-Almazán, and Alma Vázquez-Durán, and Ma Concepción Peña-Juárez, and Ricardo Vera-Graziano, and Miriam Isabel Morales-Florido, and Betsabe Rodriguez-Perez, and Isabel Marlen Rodriguez-Cruz, and Jorge Esteban Miranda-Calderón, and José Juan Escobar-Chávez
January 2006, International journal of nanomedicine,
Omar Rodrigo Guadarrama-Escobar, and Pablo Serrano-Castañeda, and Ericka Anguiano-Almazán, and Alma Vázquez-Durán, and Ma Concepción Peña-Juárez, and Ricardo Vera-Graziano, and Miriam Isabel Morales-Florido, and Betsabe Rodriguez-Perez, and Isabel Marlen Rodriguez-Cruz, and Jorge Esteban Miranda-Calderón, and José Juan Escobar-Chávez
October 2016, International journal of biological macromolecules,
Omar Rodrigo Guadarrama-Escobar, and Pablo Serrano-Castañeda, and Ericka Anguiano-Almazán, and Alma Vázquez-Durán, and Ma Concepción Peña-Juárez, and Ricardo Vera-Graziano, and Miriam Isabel Morales-Florido, and Betsabe Rodriguez-Perez, and Isabel Marlen Rodriguez-Cruz, and Jorge Esteban Miranda-Calderón, and José Juan Escobar-Chávez
August 2014, Die Pharmazie,
Omar Rodrigo Guadarrama-Escobar, and Pablo Serrano-Castañeda, and Ericka Anguiano-Almazán, and Alma Vázquez-Durán, and Ma Concepción Peña-Juárez, and Ricardo Vera-Graziano, and Miriam Isabel Morales-Florido, and Betsabe Rodriguez-Perez, and Isabel Marlen Rodriguez-Cruz, and Jorge Esteban Miranda-Calderón, and José Juan Escobar-Chávez
February 2012, Journal of materials science. Materials in medicine,
Omar Rodrigo Guadarrama-Escobar, and Pablo Serrano-Castañeda, and Ericka Anguiano-Almazán, and Alma Vázquez-Durán, and Ma Concepción Peña-Juárez, and Ricardo Vera-Graziano, and Miriam Isabel Morales-Florido, and Betsabe Rodriguez-Perez, and Isabel Marlen Rodriguez-Cruz, and Jorge Esteban Miranda-Calderón, and José Juan Escobar-Chávez
May 2016, Artificial cells, nanomedicine, and biotechnology,
Omar Rodrigo Guadarrama-Escobar, and Pablo Serrano-Castañeda, and Ericka Anguiano-Almazán, and Alma Vázquez-Durán, and Ma Concepción Peña-Juárez, and Ricardo Vera-Graziano, and Miriam Isabel Morales-Florido, and Betsabe Rodriguez-Perez, and Isabel Marlen Rodriguez-Cruz, and Jorge Esteban Miranda-Calderón, and José Juan Escobar-Chávez
December 2005, Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi,
Omar Rodrigo Guadarrama-Escobar, and Pablo Serrano-Castañeda, and Ericka Anguiano-Almazán, and Alma Vázquez-Durán, and Ma Concepción Peña-Juárez, and Ricardo Vera-Graziano, and Miriam Isabel Morales-Florido, and Betsabe Rodriguez-Perez, and Isabel Marlen Rodriguez-Cruz, and Jorge Esteban Miranda-Calderón, and José Juan Escobar-Chávez
January 2015, Current pharmaceutical design,
Omar Rodrigo Guadarrama-Escobar, and Pablo Serrano-Castañeda, and Ericka Anguiano-Almazán, and Alma Vázquez-Durán, and Ma Concepción Peña-Juárez, and Ricardo Vera-Graziano, and Miriam Isabel Morales-Florido, and Betsabe Rodriguez-Perez, and Isabel Marlen Rodriguez-Cruz, and Jorge Esteban Miranda-Calderón, and José Juan Escobar-Chávez
May 2007, Macromolecular bioscience,
Copied contents to your clipboard!